- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRK
Recent news which mentions MRK
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
November 17, 2023
From Benzinga
Merck's Gefapixant Under FDA Lens: Advisory Committee To Discuss Chronic Cough Drug's Future
November 16, 2023
Tickers
MRK
From Benzinga
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
November 16, 2023
From Benzinga
2 Healthcare Stocks That Could Make You Richer
November 15, 2023
From Motley Fool
The 3 Best Defensive Stocks for Uncertain Times
November 13, 2023
From InvestorPlace
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
November 11, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
From Benzinga
WHO’s new COVID guidelines see fewer patients requiring hospitalization
November 10, 2023
From MarketWatch
Qualcomm, Merck And 2 Other Stocks Insiders Are Selling
November 10, 2023
From Benzinga
7 Biotech Stocks to Buy for Big-Time Gains
November 10, 2023
From InvestorPlace
7 Safe Stocks to Buy if You Think Q3’s Gangbuster Growth Won’t Last
November 09, 2023
From InvestorPlace
BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial
November 08, 2023
From Benzinga
Grab these 2 funds with rich 11%-12% yields while you can
November 08, 2023
From MarketWatch
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming
November 06, 2023
From MarketWatch
Mizuho's Top Stock Picks For November Revealed
November 05, 2023
From Benzinga
Down 84% From Its Peak. Is It Finally Time to Buy Moderna?
November 05, 2023
From Motley Fool
3 Trustworthy Blue-Chip Stocks to Buy Now
November 04, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 02, 2023
From Benzinga
Moderna posts wider-than-expected loss, reins in full-year outlook
November 02, 2023
From MarketWatch
3 Dividend Stocks That Could Raise Their Payouts in November
November 02, 2023
From Motley Fool
Merck's Blockbuster Cancer Drug Keytruda Secures FDA Approval For Biliary Tract Cancer
November 01, 2023
Tickers
MRK
From Benzinga
From Motley Fool
Jim Cramer Says Hold Onto This Tech Stock, But 'You're Not Going To Make A Lot Of Money In It Right Now, Because That Was A Really Terrible Last Quarter'
October 31, 2023
From Benzinga
2 No-Brainer AI Stocks to Buy and One to Run Away From
October 31, 2023
From InvestorPlace
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
From Benzinga
3 Deeply Undervalued Growth Stocks
October 27, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.